Background: This multinational, prospective, observational study will assess the treatment and management of high- and very high-risk patients with hypercholesterolemia requiring lipid-lowering therapies in a real-world setting Trial Registration No: gov Identifier: NCT04271280 Link Sponsor: Daiichi Sankyo Trial Status: recruiting Enrolling Centers: Worldwide: 8000 participants Core Study Team Basel: